Sotera Health (SHC) Stock Forecast & Price Target
Score
Sotera Health Company price target
| SHC | |
|---|---|
| Low | $19.00 |
| Average | $21.33 |
| High | $25.00 |
| Upside vs current price | +28.4% |
The average target of $21.33 is +28.4% versus the current SHC price of $16.61.
Sotera Health Company analyst ratings
| Rating | Analysts |
|---|---|
| Strong buy | 3 |
| Buy | 5 |
| Hold | 2 |
| Sell | 0 |
| Strong sell | 1 |
| Consensus | Buy |
11 analysts cover SHC.
Sotera Health Company EPS and revenue estimates
SHC shows the next fiscal years with at least three analysts: 2026 EPS $0.98, 2027 EPS $1.07. A thinner year is left off this table.
| Fiscal year | EPS estimate | Revenue estimate |
|---|---|---|
| 2026 | $0.98 | $1.25B |
| 2027 | $1.07 | $1.32B |
Is Sotera Health Company a buy or sell?
Of the 11 analysts covering Sotera Health Company, 8 rate it a buy (3 strong buy and 5 buy), 2 rate it a hold, and 1 rates it a sell (0 sell and 1 strong sell).
The SHC consensus label is Buy, beside 8 buy-side ratings and 1 sell-side ratings.
The average target of $21.33 implies +28.4% versus the current price of $16.61.
Those 11 ratings on SHC are a headcount, and the label on file is Buy.
Reading the Sotera Health Company forecast
The SHC target band runs from $19.00 to $25.00. The average inside that band is $21.33.
Set next to the $16.61 SHC quote, that average is +28.4%.
Ratings on the Sotera Health Company cluster: 8 of 11 analysts are on the buy side, 2 are at hold, and 1 is on the sell side, and the published consensus is Buy.
Recent SHC revisions are two-sided: 0 upgrades and 1 downgrades.
The SHC EPS path from 2026 ($0.98) to 2027 ($1.07) is rising.
Only 11 analysts cover SHC, so the average rests on a short list.
Sotera Health Company forecast questions
What is the SHC price target?
The published range for SHC is $19.00 to $25.00, with an average of $21.33. That average is +28.4% versus the current price of $16.61.
Is Sotera Health Company a buy or sell?
Of the 11 analysts covering Sotera Health Company, 8 rate it a buy, 2 rate it a hold, and 1 rates it a sell. The consensus is Buy, and the SHC headcount is 8 buy, 2 hold, and 1 sell.
What is the EPS estimate for Sotera Health Company?
Analyst EPS estimates for Sotera Health Company: 2026 $0.98, 2027 $1.07.
What is the revenue estimate for Sotera Health Company?
Analyst revenue estimates for Sotera Health Company: 2026 $1.25B, 2027 $1.32B.
How many analysts cover SHC?
11 analysts cover SHC. Their consensus on SHC is Buy, across those 11.